We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the ...

Learn about respiratory viruses during viral season and how to stay safe. Dr. Matthew Muller discusses COVID-19, RSV, influenza, and more.

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...